Taipei Exchange - Delayed Quote TWD
InnoPharmax Inc. (4172.TWO)
15.70
+0.40
+(2.61%)
At close: April 25 at 2:59:59 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-76,223
-76,223
-48,572
-100,076
-50,026
Investing Cash Flow
-15,587
-15,587
-50,006
31,321
-36,601
Financing Cash Flow
219,182
219,182
97,409
18,773
-4,263
End Cash Position
166,729
166,729
39,357
40,526
90,508
Capital Expenditure
-589
-589
-397
-128
-1,450
Issuance of Capital Stock
225,000
225,000
113,600
--
20,152
Issuance of Debt
--
--
--
23,270
--
Repayment of Debt
-1,500
-1,500
-11,770
--
-20,000
Free Cash Flow
-76,812
-76,812
-48,969
-100,204
-51,476
12/31/2021 - 9/13/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6483.TWO Original BioMedicals Co., Ltd.
12.50
+0.40%
4166.TWO Orient Pharma Co., Ltd.
30.60
+0.82%
4132.TWO Golden Biotechnology Corporation
14.95
-0.33%
6467.TWO TAHO Pharma
64.40
+11.61%
6817.TWO Winston Medical Supply Co., Ltd.
97.00
+1.57%
6677.TWO Anxo Pharmaceutical Co., Ltd.
18.25
+1.11%
6932.TWO Mercury Biopharmaceutical Corporation
13.80
+7.39%
6620.TWO Handa Pharmaceuticals, Inc.
73.70
-2.12%
6621.TWO UniPharma Co., Ltd.
15.35
-3.15%
4117.TWO General Biologicals Corporation
14.45
+1.40%